Logo for Laurus Bio (formerly Richcore India)

Meet an Unreasonable Company

Laurus Bio (formerly Richcore India)

Eliminating contamination risks and creating safer medicines with animal origin free (AOF) proteins.

Photo of Subramani Ramachandrappa

Subramani Ramachandrappa

Chairman and Managing Director at Laurus Bio (formerly Richcore India)

More about Subramani »
Employees 101–200
Headquarters India
Richcore Lifesciences is a research-driven biotech company committed to making medicines safer by offering reliable, cost effective, and high-quality recombinant proteins and enzymes that replace animal derived components used in the manufacturing of medicines. Richcore offers Not of Animal Origin (NOA) recombinant proteins for regenerative medicine, stem cell research, and biotherapeutics such as insulin and vaccine manufacturing and cosmetic applications. The company has already enabled several global manufacturers of insulin and vaccines to do away with animal derived components and produce billions of doses of safer medicines by using their products. Richcore's vision and commitment is to create safer, more reliable, and more sustainable solutions to tackle current health problems. Richcore's most cost effective and affordable recombinant human albumin, is expected to replace blood plasma for therapeutic use once approved.

Currently Operating in 31 Countries

Press Mentions

July 21, 2020

Biotech company Richcore LifeSciences launches second recombinant protein manufacturing facility in Tumkur

November 29, 2020

Laurus Labs gains 7% in two days on acquisition of Richcore Lifesciences

November 25, 2020

Hyderabad-based Laurus Labs acquires a majority stake in Richcore Lifesciences

May 27, 2020

C-CAMP on Twitter

More Companies in Health

Get the Unreasonable Newsletter

Get twice-monthly updates on Laurus Bio (formerly Richcore India) and over 300 other companies working to solve the world’s toughest problems.

Read our Privacy Policy.